Blog › Longevidad

Sourcing FOXO4-DRI in Bulk: A Wholesale & White-Label Guide for EU Resellers

FOXO4-DRI is one of the most requested senolytic tool compounds in the research-peptide market. For distributors and white-label brands building a longevity-focused catalog, the sourcing question is rarely about the molecule itself: it is about supply reliability, documentation, and landed cost inside the EU. This guide is written for B2B resellers, not end users. FOXO4-DRI is a laboratory research reagent for Research Use Only (RUO), not a medicine, supplement or product for human or animal consumption.

Why EU-based stock changes the math

The single biggest variable in wholesale peptide sourcing is where the stock physically sits. Peptworks holds FOXO4-DRI (10 mg lyophilized vials) inside the EU, so orders move intra-community in 3-5 business days with no customs clearance, no import VAT surprises at the border, and no shipments stuck in inspection. For a reseller, that means predictable lead times you can promise your own customers, and no capital tied up in goods held at a frontier.

Bulk vs white-label: two ways to buy

Peptworks supports two formats. Bulk delivers unbranded vials you can catalog, repackage or distribute as-is. White-label ships the same vials labelled with your own brand and boxed, ready to resell. A one-time label setup fee of EUR 180 applies to orders under 100 units and is waived from 100 units, so at meaningful volume the branding is effectively free.

The minimum order is 10 units (one box of 10) per reference. Vials always ship in boxes of 10, which keeps handling and traceability clean.

Per-vial pricing that rewards combined volume

FOXO4-DRI is priced transparently per vial, with a single volume tier calculated on the combined total units across your whole order, not stacked per reference:

• 100 units: EUR 99.00 / vial (base)
• 300 units: EUR 81.18 / vial (-18%)
• 500 units: EUR 74.25 / vial (-25%)
• 1000 units: EUR 67.32 / vial (-32%)

Because the discount reads off your combined total, a mixed order across several references still pushes you into the better tier. Payment is by USDC bank transfer or invoice; there is no card checkout, which keeps the flow aligned with normal B2B procurement.

Documentation is the product

In research-reagent resale, your customers buy your paperwork as much as your peptide. Every FOXO4-DRI batch is tested independently by HPLC to >=98% purity and screened for heavy metals, and ships with a per-batch Certificate of Analysis. The box carries a Peptworks label with a unique QR that links directly to that batch's CoA, authenticated through Peptworks. That gives your downstream buyers a self-service way to verify identity, purity and batch traceability, which reduces support load and disputes.

Building a compliant listing

When you resell FOXO4-DRI, keep your own product pages inside the same guardrails: describe it strictly as a research reagent, reference senolytic and FOXO4-p53 research only within in-vitro and preclinical animal models, and avoid any human dosing or therapeutic language. Accurate, restrained copy protects your brand and mirrors how the supply chain is documented.

Practical takeaways

If you are scoping a first order, start with one box (10 units) per reference to validate documentation and fit, then scale into the 300-500 unit tiers where per-vial cost drops sharply and label setup becomes free. With EU stock, per-batch CoAs and a QR-verifiable box, FOXO4-DRI is a clean anchor product for a longevity research-peptide catalog. Full ordering support is available in 10 languages.

*For B2B research supply only. Not for human or animal use.*